Heterogeneous response of metastatic melanoma and multiple basal cell carcinoma to combined immune therapy with ipilimumab and nivolumab

EJC Skin Cancer · Published 2026-01-01 · DOI 10.1016/j.ejcskn.2026.101002

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.ejcskn.2026.101002

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2026

Related articles